• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞的衰老与克隆行为。

Aging and Clonal Behavior of Hematopoietic Stem Cells.

机构信息

Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai Minato-ku, Tokyo 108-8639, Japan.

出版信息

Int J Mol Sci. 2022 Feb 9;23(4):1948. doi: 10.3390/ijms23041948.

DOI:10.3390/ijms23041948
PMID:35216063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8878540/
Abstract

Hematopoietic stem cells (HSCs) are the only cell population that possesses both a self-renewing capacity and multipotency, and can give rise to all lineages of blood cells throughout an organism's life. However, the self-renewal capacity of HSCs is not infinite, and cumulative evidence suggests that HSCs alter their function and become less active during organismal aging, leading ultimately to the disruption of hematopoietic homeostasis, such as anemia, perturbed immunity and increased propensity to hematological malignancies. Thus, understanding how HSCs alter their function during aging is a matter of critical importance to prevent or overcome these age-related changes in the blood system. Recent advances in clonal analysis have revealed the functional heterogeneity of murine HSC pools that is established upon development and skewed toward the clonal expansion of functionally poised HSCs during aging. In humans, next-generation sequencing has revealed age-related clonal hematopoiesis that originates from HSC subsets with acquired somatic mutations, and has highlighted it as a significant risk factor for hematological malignancies and cardiovascular diseases. In this review, we summarize the current fate-mapping strategies that are used to track and visualize HSC clonal behavior during development or after stress. We then review the age-related changes in HSCs that can be inherited by daughter cells and act as a cellular memory to form functionally distinct clones. Altogether, we link aging of the hematopoietic system to HSC clonal evolution and discuss how HSC clones with myeloid skewing and low regenerative potential can be expanded during aging.

摘要

造血干细胞(HSCs)是唯一具有自我更新能力和多能性的细胞群体,能够在整个生物体的生命过程中产生所有的血细胞谱系。然而,HSCs 的自我更新能力并非无限的,越来越多的证据表明,HSCs 在生物体衰老过程中改变其功能并变得不那么活跃,最终导致造血平衡的破坏,如贫血、免疫失调和增加发生血液系统恶性肿瘤的倾向。因此,了解 HSCs 在衰老过程中如何改变其功能对于预防或克服这些与年龄相关的血液系统变化至关重要。最近在克隆分析方面的进展揭示了小鼠 HSC 池在发育过程中建立的功能异质性,并在衰老过程中偏向于功能稳定的 HSC 的克隆扩增。在人类中,下一代测序揭示了起源于具有获得性体细胞突变的 HSC 亚群的与年龄相关的克隆性造血,并将其突出为血液系统恶性肿瘤和心血管疾病的重要危险因素。在这篇综述中,我们总结了目前用于跟踪和可视化 HSC 克隆行为在发育过程中或应激后变化的命运图谱策略。然后,我们回顾了可以被子细胞继承并作为细胞记忆形成功能不同的克隆的与年龄相关的 HSC 变化。总之,我们将造血系统的衰老与 HSC 克隆进化联系起来,并讨论了在衰老过程中如何扩大具有髓系偏向和低再生潜能的 HSC 克隆。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/5c30787e1f4d/ijms-23-01948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/bf041d9eac1b/ijms-23-01948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/ff6fde051c86/ijms-23-01948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/5c30787e1f4d/ijms-23-01948-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/bf041d9eac1b/ijms-23-01948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/ff6fde051c86/ijms-23-01948-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c167/8878540/5c30787e1f4d/ijms-23-01948-g003.jpg

相似文献

1
Aging and Clonal Behavior of Hematopoietic Stem Cells.造血干细胞的衰老与克隆行为。
Int J Mol Sci. 2022 Feb 9;23(4):1948. doi: 10.3390/ijms23041948.
2
A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells.造血干细胞衰老的一种新机制:衰老改变了干细胞区室的克隆组成,但不影响单个干细胞。
Blood. 2008 Jun 15;111(12):5553-61. doi: 10.1182/blood-2007-11-123547. Epub 2008 Apr 15.
3
Aging of the hematopoietic system.造血系统的衰老。
Curr Opin Hematol. 2013 Jul;20(4):355-61. doi: 10.1097/MOH.0b013e3283623c77.
4
In vivo clonal analysis of aging hematopoietic stem cells.体内衰老造血干细胞的克隆分析。
Mech Ageing Dev. 2020 Dec;192:111378. doi: 10.1016/j.mad.2020.111378. Epub 2020 Oct 3.
5
Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding.通过使用细胞条码进行定量克隆分析揭示年轻和老年小鼠造血干细胞的异质性。
Blood. 2013 Jul 25;122(4):523-32. doi: 10.1182/blood-2013-01-481135. Epub 2013 May 29.
6
Age-associated changes in human hematopoietic stem cells.人类造血干细胞中与年龄相关的变化。
Semin Hematol. 2017 Jan;54(1):39-42. doi: 10.1053/j.seminhematol.2016.10.004. Epub 2016 Oct 20.
7
Epigenetics of hematopoietic stem cell aging.造血干细胞衰老的表观遗传学
Curr Opin Hematol. 2024 Jul 1;31(4):207-216. doi: 10.1097/MOH.0000000000000818. Epub 2024 Apr 12.
8
Hoxb5 defines the heterogeneity of self-renewal capacity in the hematopoietic stem cell compartment.Hoxb5 定义了造血干细胞隔室中自我更新能力的异质性。
Biochem Biophys Res Commun. 2021 Feb 5;539:34-41. doi: 10.1016/j.bbrc.2020.12.077. Epub 2021 Jan 5.
9
Aging of hematopoietic stem cells.造血干细胞的衰老。
Blood. 2018 Feb 1;131(5):479-487. doi: 10.1182/blood-2017-06-746412. Epub 2017 Nov 15.
10
Molecular mechanisms underlying lineage bias in aging hematopoiesis.衰老造血过程中谱系偏向的分子机制。
Semin Hematol. 2017 Jan;54(1):4-11. doi: 10.1053/j.seminhematol.2016.11.002. Epub 2016 Nov 20.

引用本文的文献

1
Role of the Aryl Hydrocarbon Receptor in the Self-Renewal, Differentiation, and Immunomodulation of Adult Stem Cells.芳烃受体在成体干细胞自我更新、分化及免疫调节中的作用
Immune Netw. 2025 Feb 5;25(2):e1. doi: 10.4110/in.2025.25.e1. eCollection 2025 Apr.
2
Accelerated senescence of bone marrow erythrocyte precursors in myelodysplastic syndrome.骨髓增生异常综合征中骨髓红细胞前体细胞的加速衰老。
Ann Med. 2025 Dec;57(1):2494676. doi: 10.1080/07853890.2025.2494676. Epub 2025 Apr 25.
3
A Senescent Cluster in Aged Human Hematopoietic Stem Cell Compartment as Target for Senotherapy.

本文引用的文献

1
Cell size is a determinant of stem cell potential during aging.细胞大小是衰老过程中干细胞潜能的一个决定因素。
Sci Adv. 2021 Nov 12;7(46):eabk0271. doi: 10.1126/sciadv.abk0271.
2
Resistance to inflammation underlies enhanced fitness in clonal hematopoiesis.炎症抵抗是克隆性造血增强适应性的基础。
Science. 2021 Nov 5;374(6568):768-772. doi: 10.1126/science.aba9304. Epub 2021 Nov 4.
3
Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification.简化的鼠多能祖细胞分离方案:建立多能祖细胞鉴定的共识方法。
衰老人类造血干细胞区室中的衰老细胞簇作为衰老疗法的靶点。
Int J Mol Sci. 2025 Jan 17;26(2):787. doi: 10.3390/ijms26020787.
4
Donor and recipient hematopoietic stem and progenitor cells mobilization in liver transplantation patients.肝移植患者供者和受者造血干细胞和祖细胞动员。
Stem Cell Res Ther. 2024 Jul 29;15(1):231. doi: 10.1186/s13287-024-03855-5.
5
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.当炎症应激因素发生剧烈变化时,疾病表型可能在自身免疫性造血衰竭和髓系肿瘤之间发生转变。
Front Immunol. 2024 Feb 15;15:1339971. doi: 10.3389/fimmu.2024.1339971. eCollection 2024.
6
Recurrent Aortic Thromboembolism Associated With Mutation in Chronic Myelomonocytic Leukemia.慢性粒单核细胞白血病相关的复发性主动脉血栓栓塞症。
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096231224366. doi: 10.1177/23247096231224366.
7
The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.对圣杯的追求:克服在扩大人类造血干细胞以供临床使用方面的挑战。
Stem Cell Investig. 2023 Jul 11;10:15. doi: 10.21037/sci-2023-016. eCollection 2023.
8
Biomarkers of aging.衰老的生物标志物。
Sci China Life Sci. 2023 May;66(5):893-1066. doi: 10.1007/s11427-023-2305-0. Epub 2023 Apr 11.
9
Hematopoietic Stem Cells and the Immune System in Development and Aging.造血干细胞与免疫系统的发育和衰老。
Int J Mol Sci. 2023 Mar 20;24(6):5862. doi: 10.3390/ijms24065862.
10
Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases.细胞衰老的研究:疾病的分子机制和潜在的治疗干预措施。
Signal Transduct Target Ther. 2023 Mar 14;8(1):116. doi: 10.1038/s41392-023-01343-5.
Exp Hematol. 2021 Dec;104:55-63. doi: 10.1016/j.exphem.2021.09.007. Epub 2021 Oct 11.
4
NAD augmentation with nicotinamide riboside improves lymphoid potential of Atm and old mice HSCs.烟酰胺核糖增强NAD可改善Atm缺陷小鼠和老年小鼠造血干细胞的淋巴样潜能。
NPJ Aging Mech Dis. 2021 Sep 21;7(1):25. doi: 10.1038/s41514-021-00078-3.
5
IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice.IL-1 介导微生物组诱导的小鼠造血干细胞炎症老化。
Blood. 2022 Jan 6;139(1):44-58. doi: 10.1182/blood.2021011570.
6
Clonal Hematopoiesis: From Mechanisms to Clinical Intervention.克隆性造血:从机制到临床干预。
Cancer Discov. 2021 Dec 1;11(12):2987-2997. doi: 10.1158/2159-8290.CD-21-0901.
7
Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration.化疗诱导转座元件激活 MDA5 以增强造血再生。
Nat Cell Biol. 2021 Jul;23(7):704-717. doi: 10.1038/s41556-021-00707-9. Epub 2021 Jul 12.
8
Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions.衰老的造血干细胞对血源性全身年轻化干预具有抗性。
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20210223. Epub 2021 May 25.
9
Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells.烟酰胺核糖苷可减轻造血干细胞与年龄相关的代谢和功能变化。
Nat Commun. 2021 May 11;12(1):2665. doi: 10.1038/s41467-021-22863-0.
10
Chronic interleukin-1 exposure triggers selection for Cebpa-knockout multipotent hematopoietic progenitors.慢性白细胞介素-1 暴露会引发 Cebpa 基因敲除多能造血祖细胞的选择。
J Exp Med. 2021 Jun 7;218(6). doi: 10.1084/jem.20200560.